Veracyte

- NASDAQ:VCYT
Last Updated 2024-04-19
  • Veracyte develops molecular diagnostic tests to improve patient outcomes and lower healthcare costs.
  • Locations

    • South San Francisco CA
  • Total Funding (USD)

    71.0 million
  • Industries

    Real Estate, Cyber Security
  • Security

    Type: ORD
    CUSIP: 92337F107
    ISIN: US92337F1075
Filter date
All
Bookmark Created by Last updated
Test Long URL sangwon.seo.old 2019-09-24
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.